Showing 1-7 of 7

Sorted By:

  • ARCADIA

    The purpose of this research study is to compare the effects (good and bad) of apixaban with the effects (good and bad) of aspirin in patients with unexplained strokes and atrial cardiopathy to see which is better at prevention of future strokes.

  • Breast Cancer: Alliance A011401 (Iowa Cancer Specialists)

    This study is being done to see if losing weight may help prevent breast cancer from coming back (recurring).

  • Breast Cancer: EA1131 (Iowa Cancer Specialists)

    The purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum-based chemotherapy (cisplatin or carboplatin), after surgery for patients with triple-negative breast cancer.

  • Breast Cancer: S1416 (Iowa Cancer Specialists)

    The main purpose of this study is to compare any good and bad effects of using ABT-888 (Veliparib) (a “PARP” inhibitor) along with cisplatin to using cisplatin alone.

  • Breast Cancer: S1418/BR006

    The purpose of this study is to compare the usual approach (i.e. no more treatment or additional post-operative chemotherapy), to any effects, good and/or bad, of the experimental drug MK-3475 (also called pembrolizumab) after surgery.

  • Lung Cancer: EA5142

    The purpose of this study is to find if adding the study drug, nivolumab (also known as OPVIDO®), will limit lung cancer from growing back in patients with early stage non-small cell lung cancer.

  • Rectal Cancer: NRG-GI002

    The purpose of this study is to learn if adding an experimental drug, veliparib (also known as ABT-888), to a usual treatment is better than the usual treatment alone.

Page InfoPage
Showing trials 1-7 of 7

View Additional Section Content

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email